Authorized Shares 3,998,000,000
02/07/2020
Outstanding Shares 1,659,991,381
02/07/2020
CNNA Canamed4Pets, Inc.
Follow CNNA on Twitter: @CNNA_OTC 
CNNA official twitter 7/3/19 : "Share Reduction Complete!" 
CNNA June News! 35% Reduction in OS 
AS OF 5/10/19- AN 8K WAS ISSUED BY NEW OWNERSHIP/MANAGEMENT FOR CNNA https://ih.advfn.com/stock-market/USOTC/canamed4pets-inc-CNNA/stock-news/79890424/current-report-filing-8-k Section 5 – Corporate Governance and Management
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.
On 01/28/2013 Billy V. Ray Jr. resigned as the company’s CFO.
On 01/28/2013 The company’s board of directors approved the dissolution of the company’s advisory board.
On 7/01/2015 Henrik Dahlerup resigned as the company’s Director and COO.
On 03/01/2016 Kristian Schiorring resigned as the company’s Director, President, and CEO.
On 03/01/2016 Jason Black was appointed as the company’s Director, President, and CEO. Since 2015 Mr. Black has been the President of Cann American Holdings, LLC. A California company specializing in consulting, infrastructure development, product marketing and strategic acquisitions within the legal cannabis and hemp industries.
Item 5.03 Amendments to Articles of Incorporation or Bylaws.
On 02/20/2013 The company was re-domiciled to Wyoming from Nevada.
On 11/25/2014 The company’s board of directors approved a name change from Bioflamex Corporation to Canamed4Pets, Inc.
On 12/08/2014 The company changed its name from Bioflamex Corporation to Canamed4Pets, Inc.
On 03/22/2016 The state of Wyoming administratively dissolved the company due to delinquent filings.
On 03/19/2019 The company petitioned the District Court of Wyoming for reinstatement.
On 04/30/2019 The District Court of Wyoming granted the company’s petition for reinstatement.
On 7/2/2019 The OS was reduced by 4B+ shares to 1.6B+. https://twitter.com/CNNA_OTC/status/1146121937426554885
On 12/20/2019 Canamed4pets had an official name change to Cann American Corp.
Section 9 – Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.